China NT Pharma (HKG:1011) Chief Executive Officer Ng Tit resigned effective Monday, according to a same-day filing with the Hong Kong bourse.
Ng cited the need to focus on "developing strategies for the group, the filing said. He will stay on as chairman.
Zhang Bozhi, a sales director at an associate company of China NT Pharma, will succeed Ng as CEO effective the same day.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.